Price $246.06 |
Market Cap
71.81B
|
Sector Health Care |
Div. Growth
3.20%
|
|
P/E
46.4
|
P/B
2.84
|
P/S
3.85
|
Dividend %
1.40%
|
|
P/CF
23.8
|
P/FCF
29.0
|
Op. Cash Flow
4.36M
|
FCF
8.3
|
|
Op. Margin
12.20%
|
Net Margin
8.30%
|
ROE
6.50%
|
ROI
3.30%
|
|
ROA
2.80%
|
EPS Growth
87.00%
|
Current Ratio
1.5
|
Debt/Equity
72.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.39 | - | - | 1.47B | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.91 | - | - | 959.8M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.92 | - | - | 12.34B | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.73 | - | - | 62.5M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $8.36 | - | - | 17.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
